There is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.
| Orders | Qty | Bid |
|---|---|---|
| 0 | 0 | 0 |
| 0 | 0 | 0 |
| 0 | 0 | 0 |
| 0 | 0 | 0 |
| 0 | 0 | 0 |
| Ask | Qty | Orders |
|---|---|---|
| 1477 | 5 | 49 |
| 0 | 0 | 0 |
| 0 | 0 | 0 |
| 0 | 0 | 0 |
| 0 | 0 | 0 |
Annual Revenue,rose 2.24%, in the last year to ₹29,044.6 Cr. Its sector's average revenue growth for the last fiscal year was 12.13%.Price to Earning Ratio,is 34.96, lower than its sector PE ratio of 44.99.Quarterly Revenue,rose 2.33% YoY to ₹7,330.18 Cr. Its sector's average revenue growth YoY for the quarter was 15.69%.
Founded in 1935, Cipla Limited is a global pharmaceutical company focused on making high‑quality medicines accessible across markets, guided by its purpose of “Caring for Life.” It is the third‑largest pharmaceutical company in India, ranks second in South Africa’s prescription market, is the second‑largest Indian exporter to emerging markets and seventh‑largest to Europe, and is fourth by prescriptions for generic inhalation products in the US. Its network spans 46 manufacturing sites producing 50+ dosage forms and 1,500+ products for 74 markets. Key therapeutic strengths include respiratory, anti‑retroviral, urology, cardiology, anti‑infectives and CNS. Cipla is widely recognised for enabling triple anti‑retroviral therapy for HIV/AIDS at under a dollar a day in Africa in 2001, a milestone often cited for advancing access and affordability in global health.
In India, Cipla leads respiratory therapy by market share and continues to build an innovation pipeline in complex generics and inhalation devices. Notable prescription brands include Foracort, the Dytor cardiac franchise and Urimax in urology; in consumer health, anchor brands include Nicotex, Omnigel and Cipladine.
Cipla reports five operating pillars:
The intraday high for Cipla Ltd on the NSE today (06 Aug 2026) was ₹1,488.10. This compares to the 52-week high of ₹1,673.00 recorded on 23 Oct 2025. Today's high was -11.05% below the 52-week high.
Cipla Ltd has delivered -1.88% return over the last 52 weeks. During this period, the stock hit a 52-week high of ₹1,673.00 on 23 Oct 2025 and a 52-week low of ₹1,165.70 on 02 Apr 2026. It is currently trading at ₹1,477.00 as of 06 Aug 2026.
The all-time high (ATH) for Cipla Ltd was ₹1,680.50, recorded on 09 Oct 2024. At the current price of ₹1,477.00, the stock is trading 12.11% below its all-time high. The all-time low recorded was ₹274.50 on 05 Sep 2011.
Cipla Ltd has delivered a 60.08% absolute return over the past 5 years, equivalent to a CAGR of 9.87% per annum. The stock was priced at ₹922.66 in Aug 2021 and has risen to ₹1,477.00 as of 06 Aug 2026. An investment of ₹1,00,000 in Cipla Ltd five years ago would be worth ₹1,60,080.00 today.
Yes,Cipla Ltd has declared a consistent dividend every year over the past 5 years. The company paid a total dividend of 55.50 per share between FY2022 and FY2026, with the most recent dividend of ₹13.00 per share for May 26, with an ex-dividend date of 05 Jun 2026. At the current market price of ₹1,477.00, the trailing dividend yield of Cipla Ltd stands at 29.00%.
For Q1 FY27, Cipla Ltd reported: Revenue (Net Sales): ₹50776.80 Cr - Up 20.61% year-on-year from ₹42099.80 Cr in Q4 FY26. Net Income (PAT): ₹8621.60 Cr - Up 124.15% year-on-year from ₹3846.40 Cr in Q4 FY26.
Cipla Ltd has delivered a return of 6.92% over the last 3 months. The stock was trading at ₹1,364.40 on 06 May 2026 and is currently at ₹1,477.00 as of 06 Aug 2026, reflecting a Gain of ₹112.60 per share over this period.
Over the last 6 months, Cipla Ltd has given a return of 9.68%. The stock was priced at ₹1,330.00 on 06 Feb 2026 and has Rise to ₹1,477.00 as of 06 Aug 2026, a change of ₹147.00 per share.
As of 06 Aug 2026, the share price of Cipla Ltd is ₹1,477.00 on the NSE and ₹1,475.00 on the BSE. The stock opened at ₹1,461.00, touched a high of ₹1,488.10 and a low of ₹1,443.50 during today's session.
The intraday low for Cipla Ltd on the NSE today was ₹1,443.50. The stock's 52-week low stands at ₹1,165.70, recorded on 02 Apr 2026. Today's low is 23.83% above the 52-week low, indicating the stock is trading well above its yearly lows.
